We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$959M
AUM Growth
+$89.9M
Cap. Flow
+$164M
Cap. Flow %
17.13%
Top 10 Hldgs %
50.75%
Holding
107
New
30
Increased
18
Reduced
14
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 20.26%
2 Industrials 8.56%
3 Consumer Discretionary 7.01%
4 Materials 6.46%
5 Financials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$370B
$9.54M 0.99%
+18,700
New +$9.02M
EHC icon
27
Encompass Health
EHC
$12.4B
$8.96M 0.93%
+158,382
New +$8.27M
WFC icon
28
Wells Fargo
WFC
$264B
$8.72M 0.91%
+180,000
New +$9.63M
BLMN icon
29
Bloomin' Brands
BLMN
$938M
$8.06M 0.84%
367,500
-217,500
-37% -$4.69M
Y
30
DELISTED
Alleghany Corp
Y
$8.05M 0.84%
9,500
-6,000
-39% -$4.16M
SNV
31
DELISTED
Synovus
SNV
$7.84M 0.82%
+160,000
New +$8.1M
EQH icon
32
Equitable Holdings
EQH
$14.1B
$7.73M 0.81%
250,000
+100,000
+67% +$3.3M
APLS
33
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$7.62M 0.79%
+150,000
New +$6.62M
SBNY
34
DELISTED
Signature Bank
SBNY
$7.34M 0.76%
25,000
-29,065
-54% -$9.44M
GH icon
35
CALL
Guardant Health
GH
$22.6B
$6.62M 0.69%
+100,000
New +$6.84M
QQQ icon
36
CALL
Invesco QQQ Trust
QQQ
$484B
$6.34M 0.66%
+17,500
New +$6.22M
DFS
37
DELISTED
Discover Financial Services
DFS
$6.28M 0.65%
+56,965
New +$6.69M
APO icon
38
Apollo Global Management
APO
$73.4B
$6.2M 0.65%
100,000
-55,000
-35% -$3.62M
SLGL icon
39
Sol-Gel Technologies
SLGL
$288M
$6.15M 0.64%
83,280
ALNY icon
40
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
$6.06M 0.63%
+37,100
New +$5.65M
NAPA
41
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$6.03M 0.63%
331,531
+16,448
+5% +$321K
GILD icon
42
PUT
Gilead Sciences
GILD
$165B
$5.95M 0.62%
+100,000
New +$6.39M
MIR icon
43
Mirion Technologies
MIR
$3.91B
$5.65M 0.59%
700,000
-538,500
-43% -$4.64M
ACET icon
44
Adicet Bio
ACET
$74.7M
$5.49M 0.57%
17,188
XAIR icon
45
Beyond Air
XAIR
$3.86M
$5.21M 0.54%
1,951
RDUS
46
DELISTED
Radius Health, Inc.
RDUS
$5.08M 0.53%
575,000
+250,000
+77% +$1.9M
IMGO
47
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$5.01M 0.52%
260,118
+86,288
+50% +$1.79M
FLNC icon
48
Fluence Energy
FLNC
$2.44B
$4.94M 0.52%
377,145
+87,000
+30% +$1.46M
OPTN
49
DELISTED
OptiNose
OPTN
$4.94M 0.51%
+133,333
New +$4.76M
ABT icon
50
Abbott
ABT
$187B
$4.92M 0.51%
+41,600
New +$5.16M

Similar funds

Kingdon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kingdon Capital Management held 107 positions worth $959M, up 10% from $870M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kingdon Capital Management deployed $164M of net new capital in Q1 2022, opening 30 new positions and adding to 18 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20.5M trimmed.

  • Kingdon Capital Management's largest Q1 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 289,100 shares worth $38.9M.
  • Kingdon Capital Management added most to Amazon in Q1 2022, an estimated $15.3M increase.
  • Kingdon Capital Management's biggest Q1 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.5M.
  • Kingdon Capital Management fully exited RenaissanceRe in Q1 2022, selling an estimated $29.6M.
  • Kingdon Capital Management's ten largest holdings make up 51% of its $959M portfolio in Q1 2022.
  • Kingdon Capital Management opened 30 new positions and closed 25 in Q1 2022.
  • Kingdon Capital Management's portfolio value rose 10% quarter-over-quarter to $959M.

Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.